未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Phase 1 studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 690517 (vicadrostat), a novel aldosterone synthase inhibitor, in healthy male volunteers Schulze, Friedrich; Schaible, Jennifer; Goettel, Markus; Tanaka, Yuko; Hohl, Kathrin; Schultz, Armin; Jang, In-Jin 分享 收藏
Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia Hong, Kyung Taek; Park, Hyun Jin; Kim, Bo Kyung; Choi, Jung Yoon; Song, Sang Hoon; Lee, Seunghwan; Yu, Kyung-Sang; Jang, In-Jin; Kang, Hyoung Jin 分享 收藏
分享 收藏
分享 收藏
Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose riliprubart, an anti-C1s humanized monoclonal antibody in East-Asian adults: results from a Phase 1, randomized, open-label trial Li, Yingxin; Young Na, Joo; Zhu, Yunting; Oh, Jaeseong; Zhao, Amy; Jang, In-Jin; Tang, Lei 分享 收藏
Pharmacokinetic interactions between fexuprazan, a potassium-competitive acid blocker, and nonsteroidal anti-inflammatory drugs in healthy males 健康男性中，钾竞争性酸阻滞剂非舒普赞与非甾体抗炎药之间的药代动力学相互作用 Won, Heejae; Kim, Eunwoo; Chae, Jihye; Lee, Hyejung; Cho, Joo-Youn; Jang, In-Jin; Chung, Jae-Yong; Kim, Min-Gul; Lee, SeungHwan 分享 收藏
分享 收藏
Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjects 膳食类型对新型抗肥胖药vutiglabridin在健康受试者中的生物利用度的影响 Won, Heejae; Yoon, Deok Yong; Lee, Sangmi; Cho, Joo-Youn; Oh, Jaeseong; Jang, In-Jin; Yoo, Sang-Ku; Yu, Kyung-Sang 分享 收藏
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity Yoon, Jihoon G.; Jang, Dong Geon; Cho, Sung-Gyu; Lee, Chaeyoung; Noh, Shin Hye; Seo, Soo Kyung; Yu, Jung Woo; Chung, Hyeon Woo; Han, KyeoRe; Kwon, Soon Sung; Han, Dai Hoon; Oh, Jaeseong; Jang, In-Jin; Kim, Sang-Hoon; Jee, Young-Koo; Lee, Hyun; Park, Dong Won; Sohn, Jang Won; Yoon, Ho Joo; Kim, Chul Hoon; Lee, Jae Myun; Kim, Sang-Heon; Lee, Min Goo 分享 收藏
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects Kim, Hyun Chul; Yang, Eunsol; Lee, Soyoung; Oh, Jaeseong; Lee, Myongjae; Lee, Chaeeun; Ha, Kyoung Soo; Lee, Won Sik; Jang, In-Jin; Yu, Kyung-Sang 分享 收藏
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03 interim results of a randomised, active-controlled, observer-blinded, phase 3 trial 以AS03为佐剂的SARS-CoV-2重组蛋白纳米颗粒疫苗GBP510的免疫原性和安全性随机，主动对照，观察者盲，3期试验的中期结果 Song, Joon Young; Choi, Won Suk; Heo, Jung Yeon; Kim, Eun Jin; Lee, Jin Soo; Jung, Dong Sik; Kim, Shin -Woo; Park, Kyung-Hwa; Eom, Joong Sik; Jeong, Su Jin; Lee, Jacob; Kwon, Ki Tae; Choi, Hee Jung; Sohn, Jang Wook; Kim, Young Keun; Yoo, Byung Wook; Jang, In-Jin; Capeding, Maria Z.; Roman, Francois; Breuer, Thomas; Wysocki, Piotr; Carter, Lauren; Sahastrabuddhe, Sushant; Song, Manki; D'Cor, Naveena; Kim, Hun; Ryu, Ji Hwa; Lee, Su Jeen; Park, Yong Wook; Cheng, Hee Jin 分享 收藏
分享 收藏
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects Park, Min Young; Bae, Sungyeun; Heo, Jung A.; Park, Mihee; Kim, YuKyung; Han, Jumi; Jang, In-Jin; Yu, Kyung-Sang; Oh, Jaeseong 分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
